Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Warnock

Showing results (11-20 of 209) with videos related to

Pageof 21
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 25, 2016
Competing risks: you only die onceDavid G Warnock
Hypertension (Dallas, Tex. : 1979)|March 6, 2013
The amiloride-sensitive endothelial sodium channel and vascular toneDavid G Warnock
Nephron|May 25, 2022
7th Update on Fabry Disease: Biomarkers, Progression and Treatment Opportunities in 2022David G Warnock
Nephron|February 5, 2016
Estimated Glomerular Filtration Rate: Fit for What Purpose?David G Warnock
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 2, 2009
Acute kidney injury: where's the consensus about its definition?David G Warnock
Nephron|September 1, 2016
Epilogue: UAB Symposium November 2015David G Warnock
Current Opinion in Nephrology and Hypertension|February 3, 2005
Fabry disease: diagnosis and management, with emphasis on the renal manifestationsDavid G Warnock
Kidney International. Supplement|October 16, 2004
Inclusion of albumin as a target in therapy guidelines: guidelines for chronic kidney diseaseDavid G Warnock
Journal of the American Society of Nephrology : JASN|February 22, 2014
Fabry disease: dose mattersDavid G Warnock, Michael Mauer
Nephron. Clinical Practice|November 13, 2010
Blood pressure, proteinuria and nephropathy in Fabry diseaseGaurav Jain, David G Warnock
Pageof 21

Showing results (11-20 of 209) with videos related to

Sort By:
Pageof 21
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 25, 2016
Competing risks: you only die onceDavid G Warnock
Hypertension (Dallas, Tex. : 1979)|March 6, 2013
The amiloride-sensitive endothelial sodium channel and vascular toneDavid G Warnock
Nephron|May 25, 2022
7th Update on Fabry Disease: Biomarkers, Progression and Treatment Opportunities in 2022David G Warnock
Nephron|February 5, 2016
Estimated Glomerular Filtration Rate: Fit for What Purpose?David G Warnock
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 2, 2009
Acute kidney injury: where's the consensus about its definition?David G Warnock
Nephron|September 1, 2016
Epilogue: UAB Symposium November 2015David G Warnock
Current Opinion in Nephrology and Hypertension|February 3, 2005
Fabry disease: diagnosis and management, with emphasis on the renal manifestationsDavid G Warnock
Kidney International. Supplement|October 16, 2004
Inclusion of albumin as a target in therapy guidelines: guidelines for chronic kidney diseaseDavid G Warnock
Journal of the American Society of Nephrology : JASN|February 22, 2014
Fabry disease: dose mattersDavid G Warnock, Michael Mauer
Nephron. Clinical Practice|November 13, 2010
Blood pressure, proteinuria and nephropathy in Fabry diseaseGaurav Jain, David G Warnock
Pageof 21